5-methoxytryptophan induced apoptosis and PI3K/Akt/FoxO3a phosphorylation in colorectal cancer

BACKGROUND

Colorectal cancer (CRC) is a highly prevalent malignancy worldwide, and new therapeutic targets urgently need to be found to prolong patient survival. 5-methoxytryptophan (5-MTP) is a tryptophan metabolite found in animals and humans. However, the effects of 5-MTP on proliferation and apoptosis of CRC cells are currently unknown.

AIM

To investigate the effects of 5-MTP on the proliferation, migration, invasion, and apoptosis abilities of CRC cells. Additionally, we seek to explore whether 5-MTP has the potential to be utilized as a drug for the treatment of CRC.

METHODS

In order to evaluate the effect of 5-MTP on CRC cells, a series of experiments were conducted for evaluation. Colony formation assay and Cell Counting Kit 8 assays were used to investigate the impact of 5-MTP on the proliferation of CRC cell lines. Cell cycle assays were employed to examine the effect of 5-MTP on cellular growth. In addition, we investigated the effects of 5-MTP on apoptosis and reactive oxygen species in HCT-116 cells. To obtain a deeper understanding of how 5-MTP affects CRC, we conducted a study to examine its influence on the PI3K/Akt signaling pathway in CRC cells.

RESULTS

This article showed that 5-MTP promoted apoptosis and cell cycle arrest and inhibited cell proliferation in CRC cells. In many articles, it has been reported that PI3K/Akt/FoxO3a signaling pathway is one of the most important signaling pathways involved in internal regulating cell proliferation and differentiation. Nevertheless, 5-MTP combined with PI3K/Akt/FoxO3a signaling pathway inhibitors significantly promoted apoptosis and cell cycle arrest and inhibited cell proliferation in CRC cells compared with 5-MTP alone in our study.

CONCLUSION

Therefore, there is strong evidence that 5-MTP can be used as an effective medicine for CRC treatment.

Efficient Removal of Congo Red, Methylene Blue and Pb(II) by Hydrochar-MgAlLDH Nanocomposite: Synthesis, Performance and Mechanism

Organic dyes and heavy metals often coexist in industrial effluents, and their simultaneous removal is a grand challenge. Herein, a hydrochar and MgAl layered double hydroxide (HC-MgAlLDH) nanocomposite was prepared via a facile one-step hydrothermal route, and applied to remove anionic Congo red (CR), cationic Methylene blue (MB) and Pb(II) from aqueous solutions. The nanocomposite was formed by interweaving amorphous HC and crystalline MgAlLDH nanoplates and possessed more functional groups, lower zeta potential and larger specific surface area than uncomposited MgAlLDH. Batch removal experiments showed that the components HC and LDH dominated the CR and MB removals, respectively, whereas Pb(II) removal was conjointly controlled by the two components. The maximum Langmuir removal capacities of the nanocomposite to sole CR, MB, or Pb(II) were 348.78, 256.54 or 33.55 mg/g. In binary and ternary systems, the removal capacities of CR and MB only slightly decreased, while the capacity of Pb(II) increased by 41.13-88.61%. The increase was related to the coordination of Pb(II) with the sulfur-containing groups in dyes and the precipitation of PbSO₄. Therefore, the simultaneous removal of CR, MB and Pb(II) was involved in a synergistic effect, including electrostatic adsorption, π-π interaction, coordination and precipitation. The present work shows that the HC-MgAlLDH nanocomposite has great potential for wastewater integrative treatment.

Mn3O4@polyaniline nanocomposite with multiple active sites to capture uranium(VI) and iodide: synthesis, performance, and mechanism

A major challenge for radioactive wastewater treatment and associated environmental remediation is how to simultaneously remove cationic and anionic radionuclides. Herein, a series of Mn₃O₄@polyaniline (Mn₃O₄@PANI) nanocomposites were successfully prepared and used to remove U(VI) and I^- from aqueous solution, two highly concomitant species in nuclear pollution settings. Batch adsorption experiments reveal that the component Mn₃O₄ is predominantly responsible for U(VI) removal, but PANI for I^-. The nanocomposite with 24.2 wt% Mn₃O₄ possesses high removal percentages (> 85%) either for U(VI) or I^- over a wide pH range, fast removal kinetics, and excellent adsorption selectivity at high concentrations of competing ions. Benefiting from the contributions of the two components and the high adsorption affinities, the nanocomposite achieves the simultaneous removal to coexisting U(VI) and I^-, with a maximum adsorption capacity 102.6 mg/g for U(VI) and 126.1 mg/g for I^-. X-ray photoelectron spectroscopy (XPS) results reveal that the U(VI) adsorption occurs via coordination bonding with Mn-O, -NH- , and =N- groups in the nanocomposite, whereas I^- adsorption proceeds mainly through I anionic species exchange with Cl^- and interactions with π-bonds in PANI, as well as the electrostatic attraction onto Mn₃O₄. Considering the excellent performance and multiple active sites, the Mn₃O₄@PANI nanocomposite is promising to remove practical radioactive U(VI) and I^-.

Fe3O4-Mg(OH)2 nanocomposite as a scavenger for silver nanoparticles: Rational design, facile synthesis, and enhanced performance

Silver nanoparticles (AgNPs) are considered as emerging contaminants because of their high toxicity and increasing environmental impact. Removal of discharged AgNPs from water is crucial for mitigating the health and environmental risks. However, developing facile, economical, and environment-friendly approaches remains challenging. Herein, an Fe₃O₄-Mg(OH)₂ nanocomposite, as a novel magnetic scavenger for AgNPs, was prepared by loading Fe₃O₄ nanoparticles on Mg(OH)₂ nanoplates in a one-pot synthesis. Batch removal experiments revealed that the maximum removal capacities for the two model AgNPs (citrate- or polyvinylpyrrolidone-coated AgNPs) were 476 and 442 mg/g, respectively, corresponding to partition coefficients 8.03 and 4.89 mg/g/μM. Removal feasibilities over a wide pH range of 5-11 and in real water matrices and scavenger reusability with five cycles were also confirmed. Both Fe₃O₄ and Mg(OH)₂ components contributed to the removal; however, their nanocomposites exhibited an enhanced performance because of the high specific surface area and pore volume. Chemical adsorption and electrostatic attraction between the coatings on the AgNPs and the two components in the nanocomposite was considered to be responsible for the removal. Overall, the facile synthesis, convenient magnetic separation, and high removal performance highlight the great potential of the Fe₃O₄-Mg(OH)₂ nanocomposite for practical applications.

Abiotic Formation of Calcium Oxalate under UV Irradiation and Implications for Biomarker Detection on Mars

A major objective in the exploration of Mars is to test the hypothesis that the planet has ever hosted life. Biogenic compounds, especially biominerals, are believed to serve as biomarkers in Raman-assisted remote sensing missions. However, the prerequisite for the development of these minerals as biomarkers is the uniqueness of their biogenesis. Herein, tetragonal bipyramidal weddellite, a type of calcium oxalate, is successfully achieved by UV-photolyzing pyruvic acid (PA). The as-prepared products are identified and characterized by micro-Raman spectroscopy and field emission scanning electron microscopy. Persistent mineralization of weddellite is observed with altering key experimental parameters, including pH, Ca²⁺ and PA concentrations. In particular, the initial concentration of PA can significantly influence the morphology of weddellite crystal. Oxalate acid is commonly of biological origin; thus calcium oxalate is considered to be a biomarker. However, our results reveal that calcium oxalate can be harvested by a UV photolysis pathway. Moreover, prebiotic sources of organics (e.g., PA, glycine, alanine, and aspartic acid) have been proven to be available through abiotic pathways. Therefore, our results may provide a new abiotic pathway of calcium oxalate formation. Considering that calcium oxalate minerals have been taken as biosignatures for the origin and early evolution of life on Earth and astrobiological investigations, its formation and accumulation by the photolysis of abiological organic compounds should be taken into account.

Anti-inflammatory effects of ginsenoside Rg3 on the hypertrophic scar formation via the NF-κB/IκB signaling pathway in rabbit ears

The anti-inflammatory effects of Rg3 on the hypertrophic scar (HS) formation remain relatively obscure. Hence, this study aimed to explore the anti-inflammatory effects of Rg3 on the HS formation using a rabbit ear model and we assessed the involvement of the NF-κ B/IκB signaling pathway in this process. We constructed the Newland white rabbit ear HS model and treated it with Rg3. Using histological analyses, we evaluated scar hypertrophy based on the hematoxylin and eosin staining. The degree of scarring was evaluated using the scar elevation index (SEI). In addition, collagen I and collagen III expression levels were assessed by immunohistochemistry, while fibroblast apoptosis was examined using TUNEL assays. While MPO, IL-1β, IL-6, and TNF-α concentrations were quantified using ELISA, NF-κB and p-IκB activities were respectively measured using electrophoretic mobility shift assays (EMSAs) and western blots. SEI measurements and histological characteristics revealed that Rg3 could suppress the HS formation. Moreover, Rg3 could inhibit the HS formation by decreasing collagen I and collagen III synthesis and inducing fibroblast apoptosis. Besides, Rg3 treatment markedly inhibited the inflammatory cytokine production and ameliorated neutrophil infiltration. Notably, this study revealed that Rg3 inhibited NF-κB activation and the activity of p-IκB. Furthermore, this study suggested that the ability of Rg3 to decrease the scar formation might result from its ability to inhibit inflammation by modulating the NF-κB/IκB signaling. Overall, the findings of this study could support the use of Rg3 to prevent the HS formation.

Removal and recovery of silver nanoparticles by hierarchical mesoporous calcite: Performance, mechanism, and sustainable application

The widespread use of silver nanoparticles (AgNPs) inevitably leads to the environmental release of AgNPs. The released AgNPs can pose ecological risks because of their specific toxicity. However, they can also be used as secondary sources of silver metal. Herein, hierarchical mesoporous calcite (HMC) was prepared and used to remove and recover AgNPs from an aqueous solution. The batch experiments show that the HMC has high removal percentages for polyvinylpyrrolidone- and poly (vinyl alcohol)-coated AgNPs (PVP- and PVA-AgNPs) over a wide pH range of 6-10. The adsorption isotherms indicate that the maximum removal capacities are 55 and 19 mg g^-1 for PVP-AgNPs and PVA-AgNPs, respectively, corresponding to partition coefficients (PCs) of 0.55 and 0.77 mg g^-1 μM^-1. Furthermore, the removal performance is also not impaired by coexisting anions, such as Cl^-, NO₃^-, SO₄^2-, and CO₃^2-. Their removal mechanisms can be ascribed to the electrostatic attraction and chemical adsorption between the HMC and polymer-coated AgNPs. Calcium ions on the HMC surface serve as active sites for coordination with the oxygen-bearing functional groups of AgNP coatings. Moreover, the AgNPs adsorbed onto HMC show high catalytic activity and good reusability for the reduction of the organic pollutant 4-nitrophenol. This work may pave the way not only to remove metal nanopollutants from waters but also to convert them into functional materials.

GRK5 promotes tumor progression in renal cell carcinoma

GRK5 is a multifunctional protein that is able to move within the cell in response to various stimuli to regulate key intracellular signaling from receptor activation, on plasmamembrane, to gene transcription, in the nucleus. Thus, GRK5 is involved in the development and progression of several pathological conditions including cancer. Here, we report an important tumor-promoting role for GRK5 in renal cell carcinoma (RCC). We investigated the expression pattern, clinical significance, and function of GRK5 in RCC. By using quantitative real-time polymerase chain reaction (qRT-PCR) and tissue microarray (TMA) immunohistochemistry (IHC), we first demonstrated that compared with paired adjacent nontumor (NT) tissues, RCC tissues presented with higher GRK5 expression. Moreover, we found that GRK5 upregulation was associated with poor clinical outcomes in RCC patients. In vitro, we found that GRK5 knockdown reduced viability, invasive ability, migratory ability, and decreased proportion of cells in S phase, with concomitant increase in G1 phase in RCC cell lines, while GRK5 overexpression promoted tumor cell proliferation, cell invasion, migration and increased proportion of cells in S phase, with concomitant decrease in G1 phase. Collectively, our findings describe the tumour-promoting role of GRK5 in RCC and thus provide molecular evidence for new therapeutic options in RCC.

Confirmation and refinement of a genetic locus for disseminated superficial actinic porokeratosis (DSAP1) at 12q23.2-24.1

BACKGROUND

Our previous study has identified two loci for disseminated superficial actinic porokeratosis (DSAP), but the genes responsible are still unknown.

OBJECTIVES

To narrow down the candidate regions and to assess candidate genes.

METHODS

A genome-wide scan and linkage analysis were carried out in a newly collected five-generation Chinese family with DSAP. In addition, six candidate genes were screened for possible DSAP-associated mutations.

RESULTS

DSAP in this family was associated with chromosome 12q. Fine mapping and haplotype construction refined the DSAP1 locus to a 4.4-cM interval. No disease-associated mutation was detected in CRY1, C4ST1, TXNRD1, HCF2, CMKLR1 or KIAA0789 genes.

CONCLUSIONS

The DSAP1 locus was localized to a 4.4-cM interval at chromosome 12q23.2-24.1. CRY1, C4ST1, TXNRD1, HCF2, CMKLR1 and KIAA0789 genes were not associated with DSAP1.